Skip to Main Content

Author Details

Mark N Levine
Juravinski Hospital and Cancer Center
1983
337
97
PMIDPaper TitleJournal TitlePublished Year
36731910Use of population-based electronic databases for the identification of patients with synchronous colorectal cancer and liver metastases potentially eligible for a surgical trial.Can J Surg2023
37081175Patient reported symptom burden amongst immigrant and Canadian long-term resident women undergoing breast cancer surgery.Breast Cancer Res Treat2023
37235845Impact of <sup>18</sup>F-Labeled Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Versus Conventional Staging in Patients With Locally Advanced Breast Cancer.J Clin Oncol2023
37229630Vitamin C Urinary Loss in Fabry Disease: Clinical and Genomic Characteristics of Vitamin C Renal Leak.J Nutr2023
37127137Vitamin E Induces Liver Iron Depletion and Alters Iron Regulation in Mice.J Nutr2023
35330204Pharmacologic Ascorbic Acid as Early Therapy for Hospitalized Patients with COVID-19: A Randomized Clinical Trial.Life (Basel)2022
35403753Important questions for the malignant hematologist to consider when designing or evaluating a study with patient-reported outcome measures (PROMs).Eur J Haematol2022
35606184Perioperative optimization with nutritional supplements in patients undergoing gastrointestinal surgery for cancer: A randomized, placebo-controlled feasibility clinical trial.Surgery2022
36143494Correction: Coppock et al. Pharmacologic Ascorbic Acid as Early Therapy for Hospitalized Patients with COVID-19: A Randomized Clinical Trial. <i>Life</i> 2022, <i>12</i>, 453.Life (Basel)2022
35987988Artichoke phytocomplex modulates serum microRNAs in patients exposed to asbestos: a first step of a phase II clinical trial.J Exp Clin Cancer Res2022
34878649Simultaneous resection for synchronous colorectal cancer liver metastases: A feasibility clinical trial.J Surg Oncol2022
33411700Assessment of Day-7 Postexposure Testing of Asymptomatic Contacts of COVID-19 Patients to Evaluate Early Release from Quarantine - Vermont, May-November 2020.MMWR Morb Mortal Wkly Rep2021
34880055Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial.BMJ2021
34615722Predictive Significance of an Optimized Panel for Basal-like Breast Cancer: Results from the Canadian Cancer Trials Group MA.5 and MA.12 Phase III Clinical Trials.Clin Cancer Res2021
34467257Addressing silent hypoxemia with COVID-19: Implementation of an outpatient pulse oximetry program in Vermont.Public Health Pract (Oxf)2021
34323924Metformin in Combination With Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer: The OCOG-ALMERA Randomized Clinical Trial.JAMA Oncol2021
31381464Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update.J Clin Oncol2020
31995662Treatment of cancer-associated venous thromboembolism: 12-month outcomes of the placebo versus rivaroxaban randomization of the SELECT-D Trial (SELECT-D: 12m).J Thromb Haemost2020
31634915Fatal Lyme Carditis in New England: Two Case Reports.Ann Intern Med2020
32034769Effect of PET-CT on disease recurrence and management in patients with potentially resectable colorectal cancer liver metastases. Long-term results of a randomized controlled trial.J Surg Oncol2020
33180741Virtual Cancer Care During the COVID-19 Pandemic and Beyond: A Call for Evaluation.JMIR Cancer2020
32663118Hypofractionated Breast Irradiation: What's Next?J Clin Oncol2020
32940847Anthracycline-induced cardiotoxicity in patients with early-stage breast cancer: the Canadian Cancer Trials Group (CCTG) MA.21 experience.Breast Cancer Res Treat2020
32384216Fundamental Research in Oncology and Thrombosis 2 (FRONTLINE 2): A Follow-Up Survey.Oncologist2020
30928334A meta-analysis exploring the role of PET and PET-CT in the management of potentially resectable colorectal cancer liver metastases.Eur J Surg Oncol2019
31612509Risk factors for survival following recurrence after first liver resection for colorectal cancer liver metastases.J Surg Oncol2019
31210407Incidence of delayed venous thromboembolic events in patients undergoing abdominal and pelvic surgery for cancer: a systematic review and meta-analysis.ANZ J Surg2019
31369338Learning Health System for Breast Cancer: Pilot Project Experience.JCO Clin Cancer Inform2019
29193984Population-Based Study to Determine the Health System Costs of Using the 21-Gene Assay.J Clin Oncol2018
31851740Simultaneous resection of colorectal cancer with synchronous liver metastases (RESECT), a pilot study.Int J Surg Protoc2018
30051364Venous Thromboembolic Events Following Major Pelvic and Abdominal Surgeries for Cancer: A Prospective Cohort Study.Ann Surg Oncol2018
30093531A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemia.Blood Adv2018
30646153Effect of Positron Emission Tomography Imaging in Women With Locally Advanced Cervical Cancer: A Randomized Clinical Trial.JAMA Netw Open2018
29746227Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D).J Clin Oncol2018
28045912Claudin-Low Breast Cancer; Clinical &amp; Pathological Characteristics.PLoS One2017
28379421Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials.Ann Oncol2017
28296582Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer.J Clin Oncol2017
28213002A phase II trial of dovitinib in previously-treated advanced pleural mesothelioma: The Ontario Clinical Oncology Group.Lung Cancer2017
28816169Long-Term Results of a Randomized Trial Comparing Iridium Implant Plus External Beam Radiation Therapy With External Beam Radiation Therapy Alone in Node-Negative Locally Advanced Cancer of the Prostate.Int J Radiat Oncol Biol Phys2017
27056899A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial.Oncotarget2016
26598746Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario.J Clin Oncol2016
26521036A Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation for Patients With Non-Small-Cell Lung Cancer.Clin Lung Cancer2016
27328792Positron Emission Tomography-Computed Tomography (PET-CT) Versus No PET-CT in the Management of Potentially Resectable Colorectal Cancer Liver Metastases: Cost Implications of a Randomized Controlled Trial.J Oncol Pract2016
27469239The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures.BMC Cancer2016
27130164Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol.BMJ Open2016
26711181Alemtuzumab and CHOP Chemotherapy for the Treatment of Aggressive Histology Peripheral T Cell Lymphomas: A Multi-Center Phase I Study.Clin Lymphoma Myeloma Leuk2016
25552364Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial.Breast Cancer Res Treat2015
26535517Regional Nodal Irradiation in Early-Stage Breast Cancer.N Engl J Med2015
26372731A four gene signature predicts benefit from anthracyclines: evidence from the BR9601 and MA.5 clinical trials.Oncotarget2015
26579488Correlation of baseline biomarkers with clinical outcomes and response to fulvestrant with vandetanib or placebo in patients with bone predominant metastatic breast cancer: An OCOG ZAMBONEY sub-study.J Bone Oncol2015
  • 1 - 50 of 337

Recommended Authors

Irbaz Bin Riaz
Mayo Clinic
Career Start Year 2012
Number of shared co-authors 0
Marliese Alexander
Department of Pharmacy, 5Peter MacCallum Cancer Centre
Career Start Year 2011
Number of shared co-authors 0
June M McKoy
Feinberg School of Medicine, Northwestern University
Career Start Year 2003
Number of shared co-authors 0
Nora Horick
Massachusetts General Hospital
Career Start Year 2003
Number of shared co-authors 1
Amit Bahl
University Hospitals Bristol and Weston NHS Foundation Trust
Career Start Year 2001
Number of shared co-authors 0
Andrew Eisenberger
NewYork-Presbyterian/Columbia University Irving Medical Center
Career Start Year 1997
Number of shared co-authors 0
Elizabeth Garrett-Mayer
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 2
Katherine S Panageas
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 2
Madhu Mazumdar
Icahn School of Medicine at Mount Sinai
Career Start Year 1992
Number of shared co-authors 0
Vera J Suman
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 3
Ramona F Swaby
Merck & Co., Inc.
Career Start Year 1991
Number of shared co-authors 0
Borko Jovanovic
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Career Start Year 1991
Number of shared co-authors 0
Emile E Voest
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 2
Motomi Mori
St Jude Children's Research Hospital.
Career Start Year 1988
Number of shared co-authors 0
Clifford A Hudis
Memorial Sloan Kettering Cancer Center, USA American Society of Clinical Oncology
Career Start Year 1987
Number of shared co-authors 6
Charles L Bennett
University of South Carolina
Career Start Year 1986
Number of shared co-authors 1
Paul Harnett
Westmead Clinical School, University of Sydney
Career Start Year 1986
Number of shared co-authors 3
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 5
Eric P Winer
Dana-Farber Cancer Institute
Career Start Year 1985
Number of shared co-authors 9
Stefan Aebi
University of Bern
Career Start Year 1985
Number of shared co-authors 1
Benjamin Djulbegovic
Medical University of South Carolina
Career Start Year 1985
Number of shared co-authors 0
Dianne M Finkelstein
Harvard Medical School
Career Start Year 1985
Number of shared co-authors 3
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 0
Charles L Loprinzi
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 4
Donald A Berry
MD Anderson Cancer Center
Career Start Year 1980
Number of shared co-authors 3
William R Berry
Duke Cancer Center Cary
Career Start Year 1979
Number of shared co-authors 2
Samuel M Silver
Rogel Cancer Center, University of Michigan Medical School ann arbor
Career Start Year 1978
Number of shared co-authors 1
Peter J Selby
College of Agriculture and Life Sciences, Cornell University
Career Start Year 1977
Number of shared co-authors 1
Larry Norton
Memorial Sloan Kettering Cancer Center
Career Start Year 1976
Number of shared co-authors 5
Judith D Goldberg
NYU Grossman School of Medicine
Career Start Year 1974
Number of shared co-authors 0

Collaborators

Kathleen I Pritchard
UCL Great Ormond Street Institute of Child Health, University College London
Co-authored papers 46
Lois Shepherd
Queens University
Co-authored papers 24
Gregory R Pond
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Co-authored papers 17
Steven Gallinger
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Co-authored papers 7
Anthony Fyles
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 6
David R McCready
University of Toronto, University Health Network
Co-authored papers 5
John M S Bartlett
University of Edinburgh
Co-authored papers 4
Irene L Andrulis
University of Toronto
Co-authored papers 4
Alison F Munro
Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital
Co-authored papers 2
Charles M Perou
Co-authored papers 2
Nicola Lyttle
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 2
Paul C Boutros
University of California los angeles
Co-authored papers 2
Gail Darling
University of Toronto
Co-authored papers 2
Craig C Earle
Odette Cancer Centre
Co-authored papers 2
Janet A Dunn
Warwick Clinical Trials Unit, University of Warwick
Co-authored papers 2
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Co-authored papers 2
Matthew J Ellis
Co-authored papers 2
Robert M Califf
From the National Institutes of Health
Co-authored papers 2
Melanie Spears
Ontario Institute for Cancer Research
Co-authored papers 2
Kenneth J Wilkins
National Institute of Diabetes and Digestive and Kidney Disease
Co-authored papers 1
Philippe L Bedard
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Masoom A Haider
University Health Network
Co-authored papers 1
John A Heit
Mayo Clinic
Co-authored papers 1
Catherine M Brown
Hinton State Laboratory Institute
Co-authored papers 1
Fouad Yousif
Ontario Institute for Cancer Research
Co-authored papers 1
Sherri R Davies
Co-authored papers 1
David G Huntsman
University of British Columbia
Co-authored papers 1
David Ginsburg
University of Michigan ann arbor
Co-authored papers 1
Paul Elliott
Co-authored papers 1
Susan J Done
University Health Network
Co-authored papers 1
Release 1.2